Rheumatology Practice Management October 2016 Vol 4 No 5
At the 11th Annual National Organization of Rheumatology Managers Conference, held September 15-17, 2016, in Mobile, AL, practice managers, physician managers, and other healthcare administrators gathered to network with their peers and attend educational sessions on the future of rheumatology management in the age of value-driven healthcare.
Hiring a new physician is a huge undertaking that has a lasting impact on your practice. Finding exceptional candidates who make patient safety and satisfaction a top priority benefits both your patients and your practice, because physicians who enhance your reputation are vital to long-term success.
- CMS Recruits American College of Rheumatology Leader for MACRA Committee
- Rheumatology Community Urges Congressional Leaders to Stop Medicare Part B Demo Project
- CMS Announces New Initiative to Increase Clinician Engagement
- CMS Reveals New Flexible Options for Complying with MACRA Requirements
Physicians seem to have a natural affinity for complexity. That’s a good thing for patients with difficult diagnoses, but it’s a prescription for disaster when it comes to investing. Owning a myriad of securities spread across a dozen or more financial accounts usually means more taxes, more transaction costs, less clarity, and more time spent on investing.
- Adalimumab Biosimilar Approved to Treat Multiple Indications
- First Drug for Duchenne Muscular Dystrophy Granted Accelerated Approval
- FDA Approves Etanercept Biosimilar for Multiple Indications
Mobile, AL—In a breakout session at the 2016 National Organization of Rheumatology Managers conference, Deborah Walker Keegan, PhD, FACMPE, Healthcare Business Consultant, Medical Practice Dimensions, Asheville, NC, shared 8 strategies that practice managers can use to expedite payments in today’s challenging medical reimbursement environment.
The following clinical trials represent a selection of key studies that are currently recruiting patients with lupus for inclusion in investigations of new therapies and new regimens of existing treatments for individuals with the disease. Each clinical trial description includes the NLM Identifier to be used as a reference with ClinicalTrials.gov. The information below can help rheumatology practice managers and providers direct their eligible patients to one of these clinical trials.
Results 1 - 7 of 7